Internal Medicine 2008

2008 Topics

	Additional Topics
	Associates, Residents and Fellows in Training
	Cardiology
	Career and Professionalism
	Clinical Pearls
	Computer in Practice
	Clinical Pharmacology
	Ethics and Health Policy
	Endocrinology
	Gastroenterology and Hepatology
	Health Issues Related to Age and Gender
	Hematology
	Hospital Medicine
	Infectious Diseases
	Medical Practice Management
	Multiple Small Feedings of the Mind
	Nephrology and Hypertension
	Neurology
	Oncology
	Ophthalmology and Otolaryngology
	Perioperative Medicine
	Pre-Session Courses
	Psychiatry
	Pulmonary Diseases and Critical Care
	Rheumatology and Allergy & Immunology
	Updates

Infectious Diseases in the Patient Who Is Immunocompromised by Immunomodulating Agents

Session #: 858-186
Presenter(s): Abhijit Limaye
Session Length: 1:30
Event: 2008 ACP Annual Session
Date: May 15-17, 2008

Purchase Media - Session #: 858-186
Description	Price	Qty.	Cart
MP3	$17.95		buy now
CD	$17.95		buy now
iPod Audio	$17.95		buy now
Computer AudioPoint	$24.95		buy now
iPod AudioPoint	$24.95		buy now
DOWNLOAD iPOD AUDIO FILE - Infectious Diseases in the Patient Who Is Immunocompromised by Immunomodulating Agents	$17.95		buy now
DOWNLOAD iPOD AUDIOPOINT FILE - Infectious Diseases in the Patient Who Is Immunocompromised by Immunomodulating Agents	$24.95		buy now

MTP 055
Clinical questions to be addressed:

What are the immunocompromising effects of immunomodulating agents, such as antilymphocyte agents (rituximab and alemtuzumab); tumor necrosis factor (TNF)--inhibiting agents, such as etanercept and infliximab; monoclonal antibody against TNF, such as adalimum?
Which pathogens and infections should be suspected in patients with these immunodeficiencies?
What are the infectious disease--associated treatment regimens and prevention strategies (including immunizations) for patients who are receiving these agents?